Cargando…

Increase in FeNO Levels Following IL5/IL5R-Targeting Therapies in Severe Asthma: A Case Series

PURPOSE: Monoclonal antibodies targeting interleukin-5 (IL5) and its receptor (IL5R), used for severe asthma treatment, reduce eosinophils to almost complete depletion. Fractional exhaled nitric oxide (FeNO), a surrogate marker of eosinophilic airway inflammation, is expected to decrease after their...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pelletier, Geneviève, Godbout, Krystelle, Boulay, Marie-Ève, Boulet, Louis-Philippe, Morissette, Mathieu C, Côté, Andréanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126224/ https://www.ncbi.nlm.nih.gov/pubmed/35615256 http://dx.doi.org/10.2147/JAA.S358877

Ejemplares similares

Anti-IL5/IL5R Treatment in COPD: Should We Target Oral Corticosteroid-Dependent Patients?
por: Laroche, Jérémy, et al.
Publicado: (2023)

Oral Corticosteroids Tapering in Severe Asthma
por: Boulet, Louis-Philippe, et al.
Publicado: (2021)

The Role of FeNO in Predicting Asthma
por: Pijnenburg, Mariëlle W.
Publicado: (2019)

Update on the Role of FeNO in Asthma Management
por: Murugesan, Neveda, et al.
Publicado: (2023)

The value of FeNO measurement in childhood asthma: uncertainties and perspectives
por: Ferrante, Giuliana, et al.
Publicado: (2013)

Comparison of circulating fibrocytes from non-asthmatic patients with seasonal allergic rhinitis between in and out of pollen season samples
por: Côté, Marie-Ève, et al.
Publicado: (2022)

Fractional exhaled nitric oxide (FeNo) in different asthma phenotypes
por: Gemicioglu, Bilun, et al.
Publicado: (2014)

Nasal Airflow Measured by Rhinomanometry Correlates with FeNO in Children with Asthma
por: Chen, I-Chen, et al.
Publicado: (2016)

Fractional exhaled nitric oxide (FeNO) measurement in asthma and rhinitis
por: Gevorgyan, Artur, et al.
Publicado: (2013)

The correlation between FeNO and nNO in allergic rhinitis and bronchial asthma
por: Li, Yi-Han, et al.
Publicado: (2021)

Fractional exhaled nitric oxide (FeNO): the future of asthma care?
por: Wang, Kay, et al.
Publicado: (2023)

Acute effects of nicotine-free and flavour-free electronic cigarette use on lung functions in healthy and asthmatic individuals
por: Boulay, Marie-Ève, et al.
Publicado: (2017)

FeNO and Asthma Treatment in Children: A Systematic Review and Meta-Analysis
por: Lu, Min, et al.
Publicado: (2015)

Screening Accuracy of FeNO Measurement for Childhood Asthma in a Community Setting
por: Barański, Kamil, et al.
Publicado: (2022)

FeNO as a Marker of Airways Inflammation: The Possible Implications in Childhood Asthma Management
por: Verini, Marcello, et al.
Publicado: (2010)

Could FeNO Predict Asthma in Patients with House Dust Mites Allergic Rhinitis?
por: Muntean, Ioana Adriana, et al.
Publicado: (2020)

296 The Relationship of Fractional Exhaled Nitric Oxide (FeNO) and Acute Exacerbation of Childhood Asthma
por: Rha, Yeong Ho, et al.
Publicado: (2012)

The Reliability of Adjusting Stepped Care Based on FeNO Monitoring for Patients with Chronic Persistent Asthma
por: Wang, Xiaoru, et al.
Publicado: (2019)

Economic Evaluation of the Use of FeNO for the Diagnosis and Management of Asthma Patients in Primary Care in Sweden
por: Darbà, Josep, et al.
Publicado: (2021)

Qualitative study on perceptions of use of Fractional Exhaled Nitric Oxide (FeNO) in asthma reviews
por: Santillo, Marta, et al.
Publicado: (2022)

What is the added value of FeNO as T2 biomarker?
por: Marcos, María Celeste, et al.
Publicado: (2022)

Comprehensive Fe–Ligand Vibration Identification in {FeNO}(6) Hemes
por: Li, Jianfeng, et al.
Publicado: (2014)

Guidance for a personal target value of FeNO in allergic asthma: Case report and theoretical example
por: Högman, Marieann, et al.
Publicado: (2013)

Cost-effectiveness of fractional exhaled nitric oxide (FeNO) measurement in predicting response to omalizumab in asthma
por: Brooks, Elizabeth A, et al.
Publicado: (2019)

Does FeNO Predict Clinical Characteristics in Chronic Cough?
por: Sadeghi, Mahboobeh Haji, et al.
Publicado: (2017)

Allergic Rhinitis in Preschool Children and the Clinical Utility of FeNO
por: Yoon, Jisun, et al.
Publicado: (2017)

S100A alarmins and thymic stromal lymphopoietin (TSLP) regulation in severe asthma following bronchial thermoplasty
por: Gagnon, Pierre-Alexandre, et al.
Publicado: (2023)

The effects of concomitant GERD, dyspepsia, and rhinosinusitis on asthma symptoms and FeNO in asthmatic patients taking controller medications
por: Ishizuka, Tamotsu, et al.
Publicado: (2014)

Diagnostic accuracy of FeNO in asthma and predictive value for inhaled corticosteroid responsiveness: A prospective, multicentre study
por: Schneider, Antonius, et al.
Publicado: (2022)

Anti-IL5 therapy for asthma and beyond
por: Mukherjee, Manali, et al.
Publicado: (2014)

Comparative responses to nasal allergen challenge in allergic rhinitic subjects with or without asthma
por: Rousseau, Marie-Claire, et al.
Publicado: (2011)

Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma
por: Drick, Nora, et al.
Publicado: (2020)

Treatment with interleukin (IL)-5/IL-5 receptor antibodies in patients with severe eosinophilic asthma and COPD
por: Drick, Nora, et al.
Publicado: (2022)

Factors Influencing the Concentration of Exhaled Nitric Oxide (FeNO) in School Children Aged 8–9-Years-Old in Krakow, with High FeNO Values ≥ 20 ppb
por: Czubaj-Kowal, Marta, et al.
Publicado: (2022)

Determinants of lung function changes in athletic swimmers. A review
por: Rochat, Isabelle, et al.
Publicado: (2021)

Prioritization of candidate causal genes for asthma in susceptibility loci derived from UK Biobank
por: Valette, Kim, et al.
Publicado: (2021)

Longitudinal comparison of outcomes in patients with smoking-related asthma-COPD overlap and in non-smoking asthmatics with incomplete reversibility of airway obstruction
por: Boulet, Louis-Philippe, et al.
Publicado: (2019)

Anti-IL-5 and IL-5Ra: Efficacy and Safety of New Therapeutic Strategies in Severe Uncontrolled Asthma
por: Bagnasco, Diego, et al.
Publicado: (2018)

Treating severe asthma: Targeting the IL‐5 pathway
por: Principe, Stefania, et al.
Publicado: (2021)

Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care
por: Price, David, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6162bt45sh44qgeso2i053v770